ACME UNITED CORP - 10-Q Summary (Q1 1997)
Business Context and Reporting Period
This filing covers the quarterly period ended March 31, 1997. Acme United Corporation operates in the consumer and medical products sectors. The quarter was significantly impacted by the divestiture of its German subsidiary, Altenbach, and the sale of U.S. marketing rights for certain wound care products to Seton Healthcare International Limited.
Key Financial Metrics
| Metric | Q1 1997 | Q1 1996 |
|---|---|---|
| Net Sales | $10,880,000 | $12,040,000 |
| Gross Profit Margin | 29.2% | 24.2% |
| Net Income | $281,000 | ($816,000) Loss |
| Earnings Per Share | $0.08 | ($0.24) Loss |
| Cash from Operations | ($118,000) | ($851,000) |
| Total Debt (Current + Long Term) | $14,094,000 | N/A |
| Working Capital | $8,163,000 | N/A |
| Current Ratio | 1.60 | N/A |
Material Changes vs. Prior Period
- Revenue: Consolidated net sales declined 9.6% year-over-year. However, excluding the Altenbach divestiture, organic sales increased 2%.
- Profitability: The company turned a net loss of $816,000 in Q1 1996 into a net income of $281,000 in Q1 1997. This turnaround was driven by a $849,000 gain from the Seton transaction and improved gross margins (up 500 basis points).
- Expenses: Selling, general, and administrative expenses decreased 11% due to the Altenbach divestiture and management reorganization savings, partially offset by restructuring charges.
- Restructuring: The company incurred $530,000 in restructuring and other charges, including a $692,000 asset write-down at the Bridgeport, CT facility.
Outlook, Risks, and Unusual Items
- Unusual Items: A significant one-time gain of $849,000 was recorded from the sale of U.S. marketing rights to Seton. Conversely, a $692,000 charge was taken for asset write-downs.
- Liquidity: Total debt increased by $392,000 compared to year-end 1996, primarily due to seasonality in the school products market. The company maintains a $13 million revolving line of credit with $9.48 million currently available.
- Management Commentary: Management notes that Q1 results are not necessarily indicative of full-year performance. Future debt reduction and capital expenditures are expected to be funded by operating cash flows.
- Risks: Foreign operations faced a soft European market and currency translation impacts. The company relies on asset-based lending covenants which were recently modified to allow additional availability through July 1997.
Investor Verification Checklist
- Verify the sustainability of the 29.2% gross margin excluding the one-time Seton gain and asset write-downs.
- Confirm the impact of the Altenbach divestiture on future foreign revenue streams.
- Monitor the utilization of the $13 million revolving credit line given the seasonal debt increase.
- Review the status of the Bridgeport facility asset write-down and future capital expenditure plans.
- Assess the company's ability to generate positive operating cash flow in subsequent quarters to fund debt reduction.